Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy
Other
OA: gold
CC0
⤵ 3 in-corpus citations
AI-generated summary
This study investigated the inhibition of steroid sulfatase activity in endometriotic implants using STX64 (667Coumate), proposing it as a potential new therapy for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a common and debilitating condition of women in their reproductive age that is associated with pain and infertility. Current medical treatments are only partially effective and associated with wide-ranging side effects. New understanding of local estrogen production by endometriotic tissue and the availability of powerful suppressing drugs may herald a new era in the treatment of this condition.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (11)
- Aromatase expression in endometriosis via openalex
- Endometriosis: epidemiology and aetiological factors via openalex
- Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy via openalex
- Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy via openalex
- Pathogenesis of endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Treatment of severe postmenopausal endometriosis with an aromatase inhibitor via openalex
- W2477008945 via openalex
- W1993354065 via openalex
- W4235562099 via openalex
Cited by (3)
- SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis 2018
- Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy 2008
- Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy 2007
Source provenance
- europepmc
- last seen: 2026-10-12T06:17:10.165071+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:06:07.402396+00:00
License: CC0
· commercial use OK